EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

What Shapes the Medicare Value Calculus? Exploring the Drug Price Negotiation Experience, ICER's Contributions, and Possible Paths to Greater Transparency

Marina Richardson, Daniel A Ollendorf

Health Affairs Scholar · 17.11.2026

DOI: 10.1093/haschl/qxag322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs Scholar, online erschienen am 17.11.2026. Verfasst von Marina Richardson und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Inflation Reduction Act gave Medicare new authority to negotiate the prices it pays for certain high-cost prescription drugs. As the program enters its third cycle, a central question remains: how should Medicare determine a fair price? CMS has thus far provided limited detail on how evidence about a drug’s benefits, risks, and value shapes the final negotiated price, making the process difficult for patients, manufacturers, and other stakeholders to understand or anticipate. Over three negotiation cycles, the Institute for Clinical and Economic Review (ICER) has submitted independent analyses to CMS to inform these decisions. This work has required new approaches to estimating reasonable price benchmarks, incorporating real-world evidence on clinical benefits and long-term safety, and assessing drugs used to treat multiple conditions. Drawing on this experience, we identify lessons for improving Medicare drug price negotiation and recommend greater stakeholder engagement and clearer explanations of how evidence informs negotiated prices.

Zitieren

APA

Richardson, M., & Ollendorf, D. A. (2026). What Shapes the Medicare Value Calculus? Exploring the Drug Price Negotiation Experience, ICER's Contributions, and Possible Paths to Greater Transparency. Health Affairs Scholar. https://doi.org/10.1093/haschl/qxag322

Vancouver

Richardson M, Ollendorf DA. What Shapes the Medicare Value Calculus? Exploring the Drug Price Negotiation Experience, ICER's Contributions, and Possible Paths to Greater Transparency. Health Affairs Scholar. 2026. doi:10.1093/haschl/qxag322

BibTeX
@article{Richardson2026,
  author = {Richardson, Marina and Ollendorf, Daniel A},
  title = {What Shapes the Medicare Value Calculus? Exploring the Drug Price Negotiation Experience, ICER's Contributions, and Possible Paths to Greater Transparency},
  journal = {Health Affairs Scholar},
  year = {2026},
  doi = {10.1093/haschl/qxag322}
}
Kostenlos starten →